The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Association between biofilm and multi/extensive drug resistance in diabetic foot infection
Abstract
PURPOSE: We aimed to determine significant risk factors for biofilm production and to investigate the association between antimicrobial resistance profile and biofilm formation in the bacterial isolates obtained from patients with diabetic foot infection (DFI). METHODS: Demographic, clinical, laboratory and outcome data of 165 patients, prospectively recorded and followed between January 2008 and December 2015 by a multidisciplinary committee, were analysed. Standard microbiological methods were adopted. Risk factors associated with biofilm were determined by univariate and multivariate analyses. RESULTS: The overall rate of biofilm production among 339 wound isolates was 34%. The biofilm production rate was significantly higher in Gram-negative micro-organisms (39%) in comparison with Gram positives (21%) (P = .01). A. baumannii presented the highest biofilm production (62%), followed by P. aeruginosa (52%) and Klebsiella spp. (40%). On univariate analysis, significant factors associated with biofilm were antibiotic use within last 3 months (OR:2.94, CI: 1.5-5.75, P = .002), recurrent DFI within last 6 months (OR:2.35, CI: 1.23-4.53, P = .01), hospitalisation within last 3 months due to ipsilateral recurrent DFI (OR:2.44, CI: 1.06-5.58, P = .03), presence of amputation history (OR: 2.20, CI: 1.14-4.24, P = .01), multidrug-resistant (MDR) micro-organism (OR: 7.76, CI: 4.53-13.35, P<.001) and extensively drug-resistant (XDR) micro-organism (OR:11.33, CI:4.97-26.55, P<.001). Multivariate regression analysis revealed two variables to be significant factors associated with biofilm: MDR micro-organism (OR: 3.63, CI: 1.58-8.33, P = .002) and XDR micro-organism (OR:4.06, CI: 1.25-13.1, P = .01). CONCLUSIONS: Multi/extensive drug resistance and previous recurrent DFIs were significantly associated with biofilm formation in patients with diabetic foot.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As Nisin A acts predominantly against Gram-positive bacteria, it is not suited for the treatment of polymicrobial DFI, which may correspond to up to 68% of chronic DFI [9].”
In the citing paper
“Both species belong to the ESKAPE group and are known for their multi-drug resistance profile towards commonly used antimicrobial agents, being classified as high and critical priority pathogens, respectively, in the WHO priority pathogens list for R&D of new antibiotics [8,9,10].”
In the citing paper
“These bacterial communities demonstrate high resistance to most antibacterial agents as well as to host defenses [9,15,16,17].”
In the citing paper
“These bacteria can produce several virulence factors associated to wound infection chronicity, including biofilms [5,7,9].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449 · cited 1×
“Biofilm negative (n = 26) 5 (19) 21 (81)”
James, G. A., Swogger, E., Wolcott, R., Pulcini, E. D., Secor, P., Sestrich, J., Costerton, J. W., & Stewart, P. S. (2008) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2007.00321.x · Cited by 1,543
Research works printed but not linked: 35
- Lipsky, 2016, Diabetic foot infections: current treatment and delaying the ‘post-antibiotic era’, Diabetes Metab Res Rev, 32, 246, 10.1002/dmrr.2739 · doi:10.1002/dmrr.2739
- Saltoglu, 2015, Predictors for limb loss among patient with diabetic foot infections: an observational retrospective multicentric study in Turkey, Clin Microbiol Infect, 21, 659, 10.1016/j.cmi.2015.03.018 · DOI
- Høiby, 2010, Antibiotic resistance of bacterial biofilm, Int J Antimicrob Agents, 35, 322, 10.1016/j.ijantimicag.2009.12.011 · DOI · Paper page
- Percival, 2004, Biofilms and their potential role in wound healing, Wounds, 16, 234
- Malone, 2017, Approaches to biofilm-associated infections: the need for standardized and relevant biofilm methods for clinical applications, Expert Rev Anti Infect Ther, 15, 147, 10.1080/14787210.2017.1262257 · DOI
- Percival, 2015, Biofilms and wounds: an overview of the evidence, Advances in Wound Care, 4, 373, 10.1089/wound.2014.0557 · DOI · Paper page
- Mottola, 2016, Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections, BMC Microbiol, 16, 119, 10.1186/s12866-016-0737-0 · DOI · Paper page
- Donlan, 2002, Biofilms: survival mechanisms of clinically relevant microorganisms, Clin Microbiol Rev, 15, 167, 10.1128/CMR.15.2.167-193.2002 · DOI · Paper page
- Høiby, 2015, ESCMID guideline for the diagnosis and treatment of biofilm infections 2014, Clin Microbiol Infect, 21, S1, 10.1016/j.cmi.2014.10.024 · DOI · Paper page
- Gadepalli, 2006, Clinico microbiological study of diabetic foot ulcers in an Indian tertiary care hospital, Diabetes Care, 29, 1727, 10.2337/dc06-0116 · doi:10.2337/dc06-0116
- Ramakant, 2011, Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose?, Diabetologia, 54, 58, 10.1007/s00125-010-1893-7 · doi:10.1007/s00125-010-1893-7
- Shashikala, 2016, Diabetic foot ulcers and biofilm formation, Intern J Biomed and Advance Res, 7, 428, 10.7439/ijbar.v7i9.3594 · DOI
- Murali, 2014, Characteristics of microbial drug resistance and its correlates in chronic diabetic foot ulcer infections, J Med Microbiol, 63, 1377, 10.1099/jmm.0.076034-0 · DOI
- Mah, 2001, Mechanisms of biofilm resistance to antimicrobial agents, Trends Microbiol, 9, 34, 10.1016/S0966-842X(00)01913-2 · DOI · Paper page
- Davis, 2006, The diabetic foot: the importance of biofilms and wound bed preparation, Curr Diab Rep, 6, 439, 10.1007/s11892-006-0076-x · DOI
- Lipsky, 2012, 2012 Infectious diseases society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections, Clin Infect Dis, 54, 132, 10.1093/cid/cis346 · DOI · Paper page
- Schaper, 2004, Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies, Diabetes Metab Res Rev, 20, S90, 10.1002/dmrr.464 · DOI · Paper page
- Stepanovic, 2000, A modified microtiter-plate test for quantification of staphylococcal biofilm formation, J Microbiol Methods, 40, 175, 10.1016/S0167-7012(00)00122-6 · DOI · Paper page
- Bianchi, 2016, Recommendations for the management of biofilm: a consensus document, J Wound Care, 25, 305, 10.12968/jowc.2016.25.6.305 · DOI
- Johani, 2017, Microscopy visualisation confirms multi-species biofilms are ubiquitous in diabetic foot ulcers, Int Wound J, 14, 1160, 10.1111/iwj.12777 · DOI · Paper page
- Malik, 2013, The diabetic foot infections: biofilms and antimicrobial resistance, Diabetes Metab Syndr, 7, 101, 10.1016/j.dsx.2013.02.006 · DOI
- Banu, 2015, Spectrum of bacteria associated with diabetic foot ulcer and biofilm formation: a prospective study, Australas Med J, 8, 280, 10.4066/AMJ.2015.2422 · DOI
- Mottola, 2016, Polymicrobial biofilms by diabetic foot clinical isolates, Folia Microbiol (Praha), 61, 35, 10.1007/s12223-015-0401-3 · DOI · Paper page
- Bjarnsholt, 2013, The role of bacterial biofilms in chronic infections, APMIS Suppl, 136, 1, 10.1111/apm.12099 · DOI · Paper page
- Sanchez, 2013, Biofilm formation by clinical isolates and the implications in chronic infections, BMC Infect Dis, 13, 2, 10.1186/1471-2334-13-47 · DOI · Paper page
- Rao, 2008, Correlation between biofilm production and multiple drug resistance in imipenem resistant clinical isolates of Acinetobacter baumannii, Indian J Med Microbiol, 26, 333, 10.4103/0255-0857.43566 · doi:10.4103/0255-0857.43566
- Tomaras, 2003, Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system, Microbiol, 149, 3473, 10.1099/mic.0.26541-0 · DOI · Paper page
- Zubair, 2011, A study of biofilm production by gram-negative organisms isolated from diabetic foot ulcer patients, Biol Med, 3, 147
- Vital-Lopez, 2015, Biofilm formation mechanisms of Pseudomonas aeruginosa predicted via Genome-Scale kinetic models of bacterial metabolism, PLoS Comput Biol, 11, e1004452, 10.1371/journal.pcbi.1004452 · DOI
- Colvin, 2012, The Pel and Psl polysaccharides provide Pseudomonas aeruginosa structural redundancy within the biofilm matrix, Environ Microbiol, 14, 1913, 10.1111/j.1462-2920.2011.02657.x · DOI · Paper page
- Percival, 2010, Microbiology of Wounds, 293, 10.1201/9781420079944-c11 · DOI
- Percival, 2012, A review of the scientific evidence for biofilms in wounds, Wound Repair Regen, 20, 647, 10.1111/j.1524-475X.2012.00836.x · DOI · Paper page
- Trivedi, 2014, Prevalence of multiple antibiotic resistant infections in diabetic versus nondiabetic wounds, J Pathog, 2014, 173053, 10.1155/2014/173053 · DOI
- Zubair, 2010, Clinico-bacteriology and risk factors for the diabetic foot infection with multidrug resistant microorganisms in north India, Biology and Medicine, 2, 22
- Espinal, 2012, Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces, J Hosp Infect, 80, 56, 10.1016/j.jhin.2011.08.013 · DOI · Paper page
Cited by
Lipsky, B. A., Senneville, É., Abbas, Z. G., Aragón‐Sánchez, J., Diggle, M., Embil, J. M., Kono, S., Lavery, L. A., Malone, M., van Asten, S. A., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3280 · Cited by 775
Exploring phytochemicals for combating antibiotic resistance in microbial pathogens
Khare, T., Anand, U., Dey, A., Assaraf, Y. G., Chen, Z.-S., Liu, Z., & Kumar, V. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.720726 · Cited by 281
Biofilm and wound healing: from bench to bedside
Goswami, A. G., Basu, S., Banerjee, T., & Shukla, V. K. (2023) · European Journal of Medical Research · doi:10.1186/s40001-023-01121-7 · Cited by 178
Verdial, C., Serrano, I., Tavares, L., Gil, S., & Oliveira, M. (2023) · Biomedicines · doi:10.3390/biomedicines11041221 · Cited by 71
Serrano, I., Alhinho, B., Cunha, E., Tavares, L., Trindade, A., & Oliveira, M. (2023) · Life · doi:10.3390/life13020504 · Cited by 33
Metadata
- Authors
- Vatan, A., Saltoglu, N., Yemisen, M., Balkan, I. I., Surme, S., Demiray, T., Mete, B., Tabak, F., & Study Group, C. D. F.
- Affiliations
- Cerrahpasa Medical Faculty; Infectious Diseases and Clinical Microbiology; Istanbul University; Istanbul Turkey
- Sakarya University Medical Faculty; Microbiology; Sakarya Turkey
- ORCID
- Saltoglu, Nese
- Venue
- International Journal of Clinical Practice
- Publisher
- Wiley
- Published
- 2018-01-30
- Volume
- 72
- Issue
- 3
- Pages
- e13060
- ISSN
- 1368-5031
- Cited by
- 44
- References
- 2
- Language
- en
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- onlinelibrary.wiley.com/termsAndConditions#vor (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.